I offer “de novo generation”, review, optimization and updating of all documents related to clinical development:
Effective drug development requires planning of quality assurance (QA) and quality control (QC) throughout the development program. Small issues during the course of drug development often result in big issues in the marketing approval process. Rather than fixing issues after their occurrence, preventing issues may be a better strategy.
Founder of Helion Pharma Dr. Witte